BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc.
Share Price & News
How has BlackRock Health Sciences Trust's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: BME has not had significant price volatility in the past 3 months.
7 Day Return
US Capital Markets
1 Year Return
US Capital Markets
Return vs Industry: BME underperformed the US Capital Markets industry which returned 17.9% over the past year.
Return vs Market: BME underperformed the US Market which returned 19.3% over the past year.
Price Volatility Vs. Market
How volatile is BlackRock Health Sciences Trust's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is BlackRock Health Sciences Trust undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: BME ($42.95) is trading above our estimate of fair value ($42.43)
Significantly Below Fair Value: BME is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: BME is good value based on its PE Ratio (11.5x) compared to the Capital Markets industry average (35.3x).
PE vs Market: BME is good value based on its PE Ratio (11.5x) compared to the US market (18.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BME's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: BME is good value based on its PB Ratio (1.1x) compared to the US Capital Markets industry average (6.8x).
How is BlackRock Health Sciences Trust forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Diversified Financials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as BlackRock Health Sciences Trust has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has BlackRock Health Sciences Trust performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BME has a large one-off gain of $42.7M impacting its June 30 2019 financial results.
Growing Profit Margin: BME's current net profit margins are lower than last year .
Past Earnings Growth Analysis
Earnings Trend: BME's earnings have declined by -5.1% per year over the past 5 years.
Accelerating Growth: BME's earnings growth over the past year (16%) exceeds its 5-year average (-5.1% per year).
Earnings vs Industry: BME earnings growth over the past year (16%) exceeded the Capital Markets industry 8.4%.
Return on Equity
High ROE: BME's Return on Equity (9.7%) is considered low.
Return on Assets
Return on Capital Employed
How is BlackRock Health Sciences Trust's financial position? (This company is analysed differently as a bank or financial institution)
Financial Position Analysis
Debt to Equity History and Analysis
Inventory Level: BME has a low level of unsold assets or inventory.
Debt Coverage by Assets: BME's debt is covered by short term assets (assets are 11x debt).
Financial Institutions Analysis
Asset Level: BME's level of assets compared to its equity is low.
Allowance for Bad Loans: Insufficient data to determine if BME has a sufficient allowance for bad loans.
Low Risk Liabilities: BME reports no customer deposits, loans are made up entirely of externally borrowed funds.
Loan Level: Insufficient data to determine if BME has an acceptable proportion of non-loan assets held.
Low Risk Deposits: BME has advanced significantly more loans than the customer deposits it holds.
Level of Bad Loans: Insufficient data to determine if BME has an appropriate level of bad loans.
What is BlackRock Health Sciences Trust's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: BME's dividend (5.59%) is higher than the bottom 25% of dividend payers in the US market (1.44%).
High Dividend: BME's dividend (5.59%) is in the top 25% of dividend payers in the US market (3.71%)
Stability and Growth of Payments
Stable Dividend: BME's dividend payments have been volatile in the past 10 years.
Growing Dividend: BME's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (64.4%), BME's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
BlackRock Health Sciences Trust has no CEO, or we have no data on them.
|Interested Trustee||8.1yrs||no data||no data|
|Independent Trustee||32.1yrs||US$2.26k||0.00096% $4.3k|
|Independent Trustee||15.1yrs||US$1.76k||no data|
|Independent Trustee||22.1yrs||US$2.11k||0.00096% $4.3k|
|Independent Trustee||21.1yrs||US$1.90k||no data|
|Vice Chairman of the Board||0yrs||US$2.64k||0.0048% $21.5k|
|Independent Trustee||24.1yrs||US$1.94k||no data|
|Independent Trustee||8.8yrs||US$1.94k||0.0038% $17.2k|
|Independent Trustee||16.1yrs||US$1.83k||0.0032% $14.5k|
Experienced Board: BME's board of directors are seasoned and experienced ( 18.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.9%.
BlackRock Health Sciences Trust's company bio, employee growth, exchange listings and data sources
- Name: BlackRock Health Sciences Trust
- Ticker: BME
- Exchange: NYSE
- Founded: 2005
- Industry: Asset Management and Custody Banks
- Sector: Diversified Financials
- Market Cap: US$448.887m
- Shares outstanding: 10.45m
- Website: https://www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund
- BlackRock Health Sciences Trust
- 100 Bellevue Parkway
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|BME||NYSE (New York Stock Exchange)||Yes||Common Shares||US||USD||Mar 2005|
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/21 00:17|
|End of Day Share Price||2020/02/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.